Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06393504 · ClinicalTrials.gov registry record

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

A clinical trial of Insomnia Disorder, sponsored by Idorsia Pharmaceuticals.

Active
Registry status
2,095
Enrollment target
1
Study location

NCT06393504 is a study of Insomnia Disorder that is active but no longer recruiting, run by Idorsia Pharmaceuticals. The registered enrollment target is 2,095 participants, above the 213-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (884% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06393504, a study of Insomnia Disorder, is active but no longer recruiting, sponsored by Idorsia Pharmaceuticals.

ACTIVE NOT RECRUITING
Registry status
2,095 participants
Enrollment target
1
Study location

Study Summary

Healthcare claims database study to provide safety information on maternal, fetal and infant outcomes among women exposed to QUVIVIQ (daridorexant) during pregnancy

Conditions Studied

Insomnia Disorder

Interventions

  • DRUG Daridorexant
  • OTHER No insomnia medication
  • DRUG Non-orexin receptor antagonist insomnia medication

Study Locations (1)

Delaware

  • Carelon Research - Wilmington

Trial Details

FieldValue
Enrollment Target 2,095 participants
Start Date 2023-11-30
Est. Completion 2028-04

Sponsor

Idorsia Pharmaceuticals

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06393504

The ClinicalTrials.gov registry entry for NCT06393504 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,095 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 213-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (884% higher). The listed sponsor is Idorsia Pharmaceuticals, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia Disorder appearing as the primary indexed condition, and to 3 interventions - of which Daridorexant is the first listed.

NCT06393504 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT06393504 about?

NCT06393504 is a clinical study titled "Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)". Healthcare claims database study to provide safety information on maternal, fetal and infant outcomes among women exposed to QUVIVIQ (daridorexant) during pregnancy

What is the current status of trial NCT06393504?

This trial is currently active not recruiting. The enrollment target is 2,095 participants. The study started on 2023-11-30. Estimated completion is 2028-04.

What conditions does trial NCT06393504 study?

This clinical trial studies the following conditions: Insomnia Disorder.

What interventions are being tested in trial NCT06393504?

The interventions under investigation include: Daridorexant (DRUG), No insomnia medication (OTHER), Non-orexin receptor antagonist insomnia medication (DRUG).

Who is sponsoring clinical trial NCT06393504?

This trial is sponsored by Idorsia Pharmaceuticals, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06393504 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insomnia Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insomnia Disorder

All registered trials for this condition

Delaware

All trials with a study site in Delaware

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.